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Abstract 
Introduction: The bactericidal action of many antibacterial agents has a common 
mechanism associated with the generation of hydroxyl radicals and the activation of 
oxidative stress. This is confirmed by the ratio between the degree of bactericidal effect 
and the level of hydroxyl radicals. The study of the effect of antioxidants on the 
antibacterial activity of chemotherapeutic agents can open new prospects for improving 
the treatment of infectious diseases. 
Objectives: Study of the effect of antioxidants on the activity of chemotherapeutic 
agents in relation to opportunistic bacteria 
Methods: The study examined the interaction of antibiotics (gentamicin, ciprofloxacin, 
ceftazidime) and antioxidants (ascorbic acid, N-acetylcysteine, methylethylpyridinol) in 
vitro and in vivo. We conducted a dynamic study of the effect of antioxidants at 
concentrations of 0.5, 1, 2 and 4 mM on the activity of antibacterial agents in vitro for 
three strains of Klebsiella pneumoniae and three strains of Escherichia coli. The effect 
of antioxidants on the effectiveness of antibacterial therapy was studied in Wistar rats 
with experimental bacterial peritonitis. 
Results and Discussion: In vitro studies have shown that all antioxidants reduce the 
activity of gentamicin. Methyl ethylpyridinol increases the effect of ciprofloxacin, 
ceftazidime. Ascorbic acid enhances the action of ceftazidime. Ascorbic acid, 
methylethylpyridinol and N-acetylcysteine (80 mg / kg) reduce the antibacterial activity 
of gentamicin (30 mg / kg) and ciprofloxacin (50 mg / kg) and do not change the 
intensity of peroxidation processes in combination with these antibacterial agents under 
experimental infection caused by K. pneumoniae. These antioxidants reduce the 
prooxidant effect of ciprofloxacin (50 mg / kg), without affecting its antibacterial 
activity in escherichiosis peritonitis. Ascorbic acid, methylethylpyridinol and N-
acetylcysteine (80 mg / kg) do not reduce the nephrotoxic effect of gentamicin (30 mg / 
kg). 
Conclusion: Antioxidants have anmultidirectional effect on the efficacy of antibacterial 
agents in vitro and under experimental bacterial peritonitis. Combination of antibiotics 
with antibacterial agents should be accompanied by preliminary in vitro studies. The 
rational combination of antibacterial agents and antioxidants increases the effectiveness 
of anti-infective chemotherapy and prevents the formation of resistant strains. 
Keywords: antibacterial agents, antioxidants, Klebsiella pneumoniae, Escherichia coli, 
drug interactions. 
 
Introduction 
The use of antibacterial agents has caused 
the emergence and wide spread of resistant 
microorganisms, in some cases resistant to 
several classes of antibacterial drugs [1, 2, 3]. 
Many researchers note that if existing trends do
 
Rus. 
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not change in a positive way, then medicine 
will face a problem half a century old, when 
antibiotics were not yet available [4, 5]. In this 
regard, the improvement of antimicrobial 
chemotherapy, aimed at increasing the 
effectiveness of antibacterial drugs and 
reducing the number of strains with multiple 
drug resistance, remains a very urgent task. 
Pharmacotherapy of a bacterial infection is 
usually not limited to the use of an antibacterial 
agent and includes other drugs whose effects 
are directed to the macroorganism. 
Antioxidants are used in the pharmacotherapy 
of bacterial infections because of the significant 
role of enhancing the processes of free radical 
oxidation in pathogenesis [6, 7, 8]. The use of 
the latter is considered justified, since bacterial 
infection is accompanied by the production of 
active forms of oxygen damaging biomolecules 
and making a significant contribution to the 
development of disorders of cellular 
metabolism [9, 10, 11]. According to modern 
data, the bactericidal action of many 
antibacterial agents has a common mechanism 
associated with the generation of hydroxyl 
radicals and the activation of oxidative stress in 
bacterial cells. This is confirmed by the ratio 
between the degree of bactericidal effect and 
the level of hydroxyl radicals [12, 13]. In 
addition, radical particles in low concentrations 
act as intracellular signaling molecules, 
supporting the normal course of biochemical 
processes [14, 15, 16]. Consequently, 
antioxidants can reduce the antimicrobial 
activity of chemotherapeutic agents and reduce 
the effectiveness of treatment [17]. Thus, the 
advisability of using antioxidants in 
combination with antibiotics is controversial. 
The study of the effect of antioxidants on the 
antibacterial activity of chemotherapeutic 
agents is relevant and can open new prospects 
for improving the treatment of infectious 
patients. 
Objectives 
Study of the influence of antioxidants on 
the activity of chemotherapeutic agents with 
respect to opportunistic bacteria (Escherichia 
coli and Klebsiella pneumoniae). 
 
Methods 
We studied the interaction of antioxidants 
and antibiotics (Table 1). The invitro studies 
used periodic cultures of control and clinical 
strains of the Enterobacteriaceae family: 
Escherichiacoli (control strain ATCC 25922 
and two clinical strains) and Klebsiella 
pneumoniae (control strain ATCC 13883 and 
two clinical strains). Daily cultures of the 
strains were prepared by incubation on slanted 
agar at 35 ° C and used to prepare inoculum – 
bacterial suspensions in a 0.9% sodium 
chloride solution with an optical density of 1.0 
McFarland. 
Table 1 
Antioxidants and antibiotics 
Antioxidants Antibiotics 
Ascorbic acid (Panreac, Spain) 
N-acetylcysteine (Sigma-Aldrich, USA) 
Methylethylpyridinol (MEZ, Russia) 
Gentamicin (AppliChem, Germany) 
Ciprofloxacin (Sigma-Aldrich, USA) 
Ceftazidime (Sigma-Aldrich, USA) 
 
Incubation mixtures for studying the effect 
of antioxidants on the activity of antibiotics 
were prepared on the basis of the mineral 
medium M9. The incubation mixture contained 
an antioxidant, an antibiotic and a periodic 
bacterial culture. Antioxidants were studied at 
concentrations of 0.25, 0.5, 1, 2 and 4 mM. 
Antibiotics were kept at concentrations equal to 
half the minimum inhibitory concentrations 
established for each strain. After inoculating 
the bacterial suspension, the mixture containing 
the antioxidants was incubated in an air 
thermostat at 35 ° C. for 24 hours. To assess the 
growth of strains, a device was used to 
determine the optical density of bacterial 
suspensions of Densi-la-meter (Erba Lachema 
s.r.o., Czech Republic). The measurements 
were carried out every 2 hours for 12 hours, 
and also after 24 hours of incubation. The 
obtained data were compared with the data of 
control incubation mixtures containing no 
antioxidants. 
In vivo studies were performed on 595 
male Wistar rats aged 2-3 months weighing 
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190-290 g grown in the nursery of Institute of 
Cytology and Genetics of the Siberian Branch 
of the Russian Academy of Sciences 
(Novosibirsk, Russia). The maintenance of 
animals met the requirements of the Helsinki 
Declaration of the World Medical Association 
(2000), the European Convention on the 
Protection of Vertebrates used for experimental 
or other scientific purposes (Strasbourg, 1986). 
All animals were kept in the same room in 
individual cages at an air temperature of 20-25 
° C without restriction of access to food and 
water. To carry out the research, healthy 
animals were selected who had undergone a 
two-week quarantine in the vivarium. The 
experimental groups were formed by random 
sampling, taking into account the body weight 
as the determining index. 
The in vivo experiments were divided into 
2 parts according to the number of 
microorganisms studied (Escherichia coli, 
Klebsiella pneumoniae). Each part was divided 
into 5 series in accordance with the 
antibacterial agents studied. For each series of 
35 animals, groups (1-5) of 7 individuals were 
formed. 
In each series, the animals of all groups 
were injected intraperitoneally with a bacterial 
suspension (2.5 units by McFarland, 5 ml / kg) 
obtained from a daily pure culture of a clinical 
strain of Escherichia coli or Klebsiella 
pneumoniae. 3 hours after injection, a sterile 
solvent of antibacterial agent was administered 
to animals of Group 1, Group 2 – solution of 
antibacterial agent, Group 3 – sequential 
solutions of antibacterial agent and ascorbic 
acid, Group 4 – solutions of antibacterial agent 
and methylethylpyridinol, Group 5 – solutions 
of antibacterial agent and N-acetylcysteine. 
Antibiotics were administered in doses: 
gentamicin 30 mg/kg, ciprofloxacin 50 mg/kg, 
ceftazidime 120 mg/kg. Antioxidants were 
administered in a dose 80 mg/kg. After 18 
hours, the blood of experimental animals 
underwent biochemical studies. 
To assess the free radical oxidation in the 
blood plasma of rats, the concentrations of 
ceruloplasmin, thiobarbiturate-reactive 
products of the plasma were measured, in 
erythrocytes – the concentration of reduced 
glutathione, the activity of glutathione 
peroxidase and catalase. Ceruloplasmin was 
also determined as a marker of the intensity of 
the inflammatory process.  
To assess liver function in blood plasma, 
the activity of alanine aminotransferase and 
alkaline phosphatase was determined. The renal 
function was assessed by plasma concentrations 
of urea and creatinine. These parameters were 
determined using diagnostic kits (Vital 
Diagnostics SPb, Russia). 
Computer programs Microsoft Office 
Excel 2003 (Microsoft Corporation, USA) and 
SigmaStat 3.5 (Systat Software Inc., USA) for 
Windows were used for calculations. The 
statistical processing of the results was carried 
out using the nonparametric criteria of Kraskel-
Wallis and Mann-Whitney. The data were 
presented as a median and interquartile range – 
Me (25%, 75%). Differences were considered 
significant at P≤0.05 (comparison of two 
independent groups) and at P≤0.017 (pairwise 
comparison of three independent groups). 
 
Results and Discussion  
Interaction between antibacterial agents 
and antioxidants in vitro 
The results of a study of the modulation of 
the activity of antibacterial agents by 
antioxidants in vitro are presented in Table 2. 
There is a pronounced antagonism between 
gentamicin and antioxidants, which indicates 
an important role of enhancing the processes of 
peroxidation in the course of the bactericidal 
action of the antibiotic. Note that 
aminoglycosides – this is the only class of 
inhibitors of protein biosynthesis, which has a 
bactericidal effect. This is confirmed by  
M.A. Kohansky et al. (2007), which proved the 
leading role of free radical oxidation in the 
realization of this effect [12]. 
Glutathione, as a natural metabolite of the 
microorganisms under consideration, provides 
universal protection against active forms of 
oxygen [18]. In connection with this, the 
expected decrease is the activity of 
ciprofloxacin and ceftazidime, antibiotics with 
a proven prooxidant component in the 
mechanism of action [12], under the action of 
N-acetylcysteine, a precursor of glutathione. 
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Table 2  
Interaction between antibacterial agents and antioxidants in vitro 
 
Antioxidant 
Escherichiacoli Klebsiellapneumoniae 
Strain 1 Strain 2 Strain 3 Strain 1 Strain 2 Strain 3 
Gentamicin 
Ascorbic acid А++ А++ А++ А++ А++ А++ 
Methylethylpyridinol А++ А++ А++ А++ А++ А++ 
N-acetylcysteine А++ А++ А++ А++ А++ А++ 
Ciprofloxacin 
Ascorbic acid 0 0 0 0 А+ А++ 
Methylethylpyridinol S 0 S S++ S S 
N-acetylcysteine А++ А++ А++ А А++ А++ 
Ceftazidime 
Ascorbic acid S S S S S S 
Methylethylpyridinol S S S S S S 
N-acetylcysteine А++ А++ А++ А++ А++ А+ 
Note. Antagonism: A ++ – within 24 hours of incubation; A + – in most cases, the dependence on the 
concentration of the antioxidant may be absent; A – episodic development of culture is higher than control, 
dependence on antioxidant concentration may be absent; 0 – no influence, the development of culture does not 
change, or there are point changes with respect to control. Synergy: S – episodic development of culture below 
control, dependence on antioxidant concentration may be absent; S + – in most cases, the dependence on the 
concentration of the antioxidant may be absent; S ++ – within 24 hours of incubation. 
 
The effect of ascorbic acid on the activity 
of antibacterial agents has no obvious picture. 
The reason for this is the chemical instability of 
the ascorbic acid molecule under aerobic 
conditions and the ability of the substance to 
act as a pro-oxidant [19]. 
The independent antibacterial activity of 
methyl ethylpyridinol was demonstrated by us 
earlier [20]. It has been established that methyl 
ethylpyridinol enhances the action of all 
antibacterial agents studied, with the exception 
of gentamicin, against most strains, with the 
strongest effect being manifested in high 
concentrations of the antioxidant. This fact 
testifies, first, the lack of competition for a 
pharmacological target, and secondly, the 
insignificant effect of the antioxidant properties 
of methyl ethyl pyridinol on the action of pro-
oxidants. At the same time, with the incubation 
with gentamicin, methyl ethyl pyridinol 
showed the most pronounced antagonistic 
activity compared to other antioxidants. In this 
regard, it appears that methylethylpyridinol has 
an antibacterial mechanism of action similar to 
aminoglycosides, although less pronounced. 
Interaction between antibacterial agents 
and antioxidants in vivo 
Consider the results of a study modulating 
chemotherapy with the use of gentamicin 
(Tables 3 and 4).It should be noted that this 
particular antibiotic causes the greatest 
alertness when administered with antioxidants, 
since the latter resulted in the appearance of 
almost complete antibiotic resistance in vitro. 
The described effect eventually manifested 
itself in animals with experimental peritonitis – 
a significant decrease in the concentration of 
ceruloplasmin is observed only in the regime of 
monotherapy with an antibiotic, the 
introduction of antioxidants completely 
neutralizes this effect. The severity of leaking 
peritonitis is enhanced by renal dysfunction 
developing in animals receiving gentamicin due 
to the implementation of the nephrotoxic 
properties of the antibiotic. 
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Table 3 
Biochemical indices of rats with bacterial peritonitis caused by Escherichia coli 
 (with gentamicin administration) 
P Group 1 Group 2 Group 3 Group 4 Group 5 
Erythrocyte catalase activity, %/mg Hb 
 
0.030 
(0.026;0.043) 
0.049 
(0.045;0.054) 
0.041 
(0.037;0.047) 
0.036 
(0.029;0.060) 
0.046 
(0.043;0.060) 
P x 0.038 0.097 0.383 0.038 
Concentration of reduced glutathione in erythrocytes,umol/g Hb 
 
0.56 
(0.49;0.61) 
0.78 
(0.68;0.79) 
0.74 
(0.56;0.82) 
0.70 
(0.63;0.77) 
0.70 
(0.55;0.73) 
P x 0.004 0.097 0.026 0.128 
Erythrocyte glutathione peroxidase activity,umol/(min× g Hb) 
 
18.11 
(17.37;20.80) 
19.62 
(17.61;22.31) 
17.15 
(13.48;21.54) 
18.84 
(16.72;20.80) 
19.32 
(17.28;22.36) 
P x 0.710 0.535 1.000 0.620 
Concentration of thiobarbiturate-reactive products,umol/l 
 
4.88 
(3.26;5.11) 
4.65 
(3.63;5.88) 
4.26 
(3.73;4.61) 
3.76 
(3.44;4.41) 
3.64 
(3.22;4.24) 
P x 0.710 0.805 0.535 0.535 
Concentration of ceruloplasmin,mg/l 
 
512.8 
(481.7;571.8) 
455.0 
(418.0;489.1) 
511.0 
(440.1;523.5) 
518.0 
(499.2;598.5) 
522.4 
(414.5;541.8) 
P x 0.017 0.456 0.535 0.902 
Alanine aminotransferase activity in plasma,umol/(sec×l) 
 
1.13 
(0.85;1.48) 
1.22 
(0.77;1.29) 
1.21 
(1.02;1.36) 
1.26 
(1.08;1.59) 
1.28 
(0.96;1.40) 
P x 0.902 1.000 0.620 1.000 
Activity of alkaline phosphatase in plasma,nmol/(sec×l) 
 
1758 
(1609;1920) 
1517 
(1287;1713) 
1665 
(1124;1744) 
1625 
(1238;1903) 
1517 
(1378;1638) 
P 
x 0.073 0.209 0.383 0.073 
Urea concentration in plasma,mmol/l 
 
2.48 
(2.23;2.67) 
5.08 
(4.14;7.03) 
4.26 
(3.62;4.65) 
5.13 
(4.06;6.47) 
4.89 
(3.74;5.21) 
P x <0.001 <0.001 <0.001 0.011 
Concentration of creatinine in plasma,umol/l 
 
66.3 
(60.7;70.3) 
76.4 
(75.3;94.5) 
80.4 
(72.9;88.3) 
89.9 
(77.8;110.0) 
93.9 
(81.9;106.2) 
P x 0.001 0.026 0.002 0.011 
 
The administration of gentamicin, as well 
as its combination with methylethylpyridinol, 
prevents the formation of a deficit of reduced 
glutathione in animals with E. coli-induced 
peritonitis. In animals with peritonitis caused 
by Klebsiella pneumoniae, this effect is absent. 
However, neither the antibiotic nor its 
combination with antioxidants in both cases 
reduces the concentration of thiobarbiturate-
reactive products in plasma under experimental 
peritonitis. This can be due, firstly, to the pro-
oxidant properties of gentamicin, which do not 
allow to reduce the intensity of the processes of 
free radical oxidation even when the pathogen 
is destroyed, and secondly, the renal function is 
impaired, and accordingly, the elimination of 
lipid peroxidation products. 
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Table 4 
Biochemical indices of rats with bacterial peritonitis caused by Klebsiella pneumoniae  
(with gentamicin administration) 
 
P Group 1 Group 2 Group 3 Group 4 Group 5 
Erythrocyte catalase activity, %/mg Hb 
 
0.048 
(0.044;0.052) 
0.030 
(0.023;0.035) 
0.049 
(0.047;0.052) 
0.049 
(0.045;0.051) 
0.050 
(0.044;0.059) 
P x 0.001 0.535 0.805 0.805 
Concentration of reduced glutathione in erythrocytes, umol/g Hb 
 
0.55 
(0.47;0.67) 
0.61 
(0.45;0.63) 
0.46 
(0.42;0.57) 
0.52 
(0.48;0.56) 
0.47 
(0.45;0.54) 
P x 1.000 0.456 0.710 0.383 
Erythrocyte glutathione peroxidase activity, umol/(min× g Hb) 
 
18.28 
(14.44;19.22) 
16.27 
(14.01;17.64) 
16.92 
(16.78;17.48) 
17.40 
(16.21;18.35) 
17.43 
(16.47;19.17) 
P x 0.259 1.000 0.902 0.710 
Concentration of thiobarbiturate-reactive products, umol/l 
 
3.57 
(3.43;3.67) 
3.49 
(2.70;3.59) 
3.52 
(3.14;3.76) 
3.60 
(2.96;4.15) 
3.45 
(3.36;3.92) 
P x 0.318 1.000 0.805 0.620 
Concentration of ceruloplasmin, mg/l 
 
496.1 
(459.6;592.2) 
406.0 
(382.8;423.7) 
462.9 
(408.4;528.7) 
450.6 
(446.0;518.4) 
447.1 
(438.1;500.5) 
P x 0.017 0.259 0.259 0.209 
Alanine aminotransferase activity in plasma, umol/(sec×l) 
 
2.32 
(1.98;2.56) 
1.73 
(1.71;1.96) 
1.96 
(1.76;2.17) 
2.27 
(1.90;2.31) 
1.97 
(1.95;2.22) 
P x 0.017 0.128 0.383 0.318 
Activity of alkaline phosphatase in plasma, nmol/(sec×l) 
 
1493 
(1281;1558) 
1301 
(1183;1486) 
1286 
(1210;1492) 
1304 
(1221;1482) 
1431 
(1222;1522) 
P x 0.318 0.383 0.383 0.456 
Urea concentration in plasma, mmol/l 
 
2.25 
(1.94;2.56) 
4.67 
(4.48;5.15) 
4.81 
(4.60;5.39) 
5.29 
(4.40;5.62) 
4.81 
(4.41;5.40) 
P x <0.001 <0.001 <0.001 <0.001 
Concentration of creatinine in plasma, umol/l 
 
55.8 
(49.4;60.0) 
95.6 
(88.3;105.7) 
96.1 
(89.5;102.4) 
98.1 
(90.9;107.6) 
96.9 
(86.1;105.0) 
P х <0.001 <0.001 <0.001 <0.001 
 
The administration of ciprofloxacin 
reduces the oxidase activity of ceruloplasmin, 
and this effect in rats with peritonitis induced 
by E. coli, is preserved both in the 
monochemotherapy regimen and in co-
administration with antioxidants (Table 5).  
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Table 5  
Biochemical indices of rats with bacterial peritonitis caused by Escherichia coli  
(with ciprofloxacin administration) 
 
P Group 1 Group 2 Group 3 Group 4 Group 5 
Erythrocyte catalase activity, %/mg Hb 
 
0.042 
(0.033;0.051) 
0.038 
(0.035;0.044) 
0.039 
(0.028;0.048) 
0.042 
(0.030;0.050) 
0.038 
(0.029;0.055) 
P x 0.456 0.318 0.535 0.710 
Concentration of reduced glutathione in erythrocytes, umol/g Hb 
 
0.55 
(0.52;0.65) 
0.73 
(0.65;0.76) 
0.72 
(0.63;0.82) 
0.63 
(0.50;0.88) 
0.62 
(0.54;0.67) 
P x 0.011 0.026 0.456 0.456 
Erythrocyte glutathione peroxidase activity, umol/(min× g Hb) 
 
13.31 
(12.92;16.99) 
14.69 
(12.26;17.07) 
18.90 
(16.07;19.74) 
19.39 
(17.55;20.41) 
19.23 
(17.78;21.12) 
P х 0.902 0.026 0.038 0.026 
Concentration of thiobarbiturate-reactive products, umol/l 
 
4.69 
(4.52;4.92) 
3.95 
(3.59;4.49) 
4.65 
(4.53;4.68) 
3.64 
(3.39;4.42) 
4.11 
(3.75;4.31) 
P x 0.017 0.535 0.004 0.004 
Concentration of ceruloplasmin, mg/l 
 
536.4 
(499.8;601.3) 
383.3 
(350.4;465.7) 
471.6 
(393.1;491.8) 
461.1 
(437.5;476.7) 
410.4 
(394.4;488.9) 
P x 0.004 0.026 0.017 0.026 
Alanine aminotransferase activity in plasma, umol/(sec×l) 
 
1.93 
(1.84;2.53) 
1.87 
(1.83;1.90) 
1.77 
(1.62;2.09) 
1.80 
(1.74;1.99) 
1.77 
(1.67;1.96) 
P x 0.383 0.209 0.165 0.128 
Activity of alkaline phosphatase in plasma, nmol/(sec×l) 
 
1458 
(1438;1866) 
1464 
(1397;1530) 
1304 
(1280;1589) 
1458 
(1292;1560) 
1319 
(1250;1821) 
P x 0.456 0.259 0.456 0.165 
Urea concentration in plasma, mmol/l 
 
1.56 
(1.41;2.08) 
1.78 
(1.55;2.08) 
1.93 
(1.72;2.03) 
1.78 
(1.64;1.89) 
1.62 
(1.57;1.80) 
P x 0.456 0.383 0.383 0.805 
Concentration of creatinine in plasma, umol/l 
 
46.8 
(45.2;49.3) 
51.8 
(48.9;54.5) 
50.8 
(49.7;53.1) 
51.3 
(48.6;53.0) 
50.3 
(50.1;53.2) 
P x 0.165 0.209 0.259 0.165 
 
The concentration of thiobarbiturate-
reactive products in animals with E. coli-
induced peritonitis decreases with 
ciprofloxacin, indicating a decrease in the 
intensity of peroxidation processes. This effect 
is observed despite the known pro-oxidant 
properties of ciprofloxacin. In this regard, it can 
be argued that a decrease in the intensity of 
peroxidation is associated with the antibacterial 
action of ciprofloxacin, and the elimination of 
products of peroxidation and endotoxins is not 
hampered by the preserved functions of the 
liver and kidneys. Important is the fact that the 
administration of antioxidants increases the 
activity of glutathione peroxidase. Untypical is 
the profile of peroxidation markers in animals 
with escherichial peritonitis who received 
ciprofloxacin with ascorbic acid. On the one 
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hand, the concentration of thiobarbiturate-
reactive products is maintained at the control 
level, which indicates the lack of realization of 
its antioxidant properties by ascorbic acid. On 
the other hand, the concentration of reduced 
glutathione is at the same level as the 
monotherapy group. This is probably due to the 
dual properties of ascorbic acid, which, 
depending on the conditions, can be both anti- 
and pro-oxidant. 
The administration of antioxidants to 
animals with K. pneumoniae infection retains 
the activity of ceruloplasmin at the control 
level, which indirectly may indicate a decrease 
in the effectiveness of treatment (Table 6).  
Table 6 
Biochemical indices of rats with bacterial peritonitis caused by Klebsiella pneumonia 
(with ciprofloxacinadministration) 
 
P Group 1 Group 2 Group 3 Group 4 Group 5 
Erythrocyte catalase activity, %/mg Hb 
 
0.053 
(0.048;0.057) 
0.046 
(0.036;0.049) 
0.046 
(0.034;0.048) 
0.040 
(0.038;0.050) 
0.048 
(0.039;0.053) 
P x 0.038 0.026 0.038 0.209 
Concentration of reduced glutathione in erythrocytes, umol/g Hb 
 
0.64 
(0.61;0.72) 
0.63 
(0.59;0.69) 
0.68 
(0.63;0.80) 
0.84 
(0.59;0.87) 
0.66 
(0.63;0.81) 
P x 0.620 0.318 0.383 0.535 
Erythrocyte glutathione peroxidase activity, umol/(min× g Hb) 
 
11.63 
(10.37;15.27) 
16.94 
(14.26;18.44) 
13.04 
(11.89;14.10) 
12.35 
(11.06;14.03) 
15.11 
(13.16;15.25) 
P х 0.097 0.535 0.805 0.620 
Concentration of thiobarbiturate-reactive products, umol/l 
 
4.26 
(3.71;4.93) 
4.26 
(3.74;4.84) 
4.34 
(3.91;4.47) 
4.34 
(3.94;4.47) 
3.84 
(3.71;4.36) 
P x 0.805 0.902 0.902 0.535 
Concentration of ceruloplasmin, mg/l 
 
468.1 
(446.3;529.8) 
427.0 
(399.9;446.3) 
406.0 
(404.0;439.5) 
415.6 
(397.0;491.3) 
445.4 
(424.6;468.3) 
P x 0.038 0.053 0.165 0.209 
Alanine aminotransferase activity in plasma, umol/(sec×l) 
 
1.99 
(1.94;2.40) 
1.86 
(1.73;2.00) 
2.25 
(2.00;2.56) 
2.08 
(1.83;2.40) 
2.03 
(1.74;2.25) 
P x 0.165 0.535 1.000 0.456 
Activity of alkaline phosphatase in plasma, nmol/(sec×l) 
 
1515 
(1368;1942) 
1328 
(1287;1619) 
1541.8 
(1361;1718) 
1325 
(1270;1757) 
1524 
(1316;1641) 
P x 0.209 0.620 0.318 0.620 
Urea concentration in plasma, mmol/l 
 
1.98 
(1.88;2.30) 
1.96 
(1.89;2.29) 
1.99 
(1.86;2.11) 
2.23 
(1.76;2.35) 
2.01 
(1.87;2.29) 
P x 0.902 0.805 0.902 0.902 
Concentration of creatinine in plasma, umol/l 
 
48.3 
(46.6;55.5) 
45.1 
(45.1;50.2) 
55.3 
(45.6;56.2) 
57.1 
(46.1;57.5) 
53.8 
(47.7;59.1) 
P x 0.128 1.000 0.710 0.620 
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Table 7 
Biochemical indices of rats with bacterial peritonitis caused by Escherichia coli  
(with ceftazidimeadministration) 
 
P Group 1 Group 2 Group 3 Group 4 Group 5 
Erythrocyte catalase activity, %/mg Hb 
 
0.048 
(0.035;0.051) 
0.027 
(0.019;0.038) 
0.029 
(0.026;0.032) 
0.031 
(0.021;0.033) 
0.031 
(0.029;0.035) 
P x 0.026 0.001 0.007 0.017 
Concentration of reduced glutathione in erythrocytes, umol/g Hb 
 
0.52 
(0.38;0.58) 
0.67 
(0.56;0.76) 
0.67 
(0.62;0.74) 
0.68 
(0.64;0.72) 
0.68 
(0.67;0.71) 
P x 0.038 0.038 0.017 0.011 
Erythrocyte glutathione peroxidase activity, umol/(min× g Hb) 
 
16.77 
(14.48;17.72) 
19.07 
(18.11;22.71) 
20.09 
(19.73;22.26) 
21.57 
(19.71;22.11) 
21.48 
(18.63;22.91) 
P х 0.007 0.002 0.002 0.026 
Concentration of thiobarbiturate-reactive products, umol/l 
 
4.38 
(3.89;4.60) 
2.79 
(2.34;3.71) 
2.87 
(2.51;3.30) 
3.29 
(3.23;3.58) 
2.91 
(2.27;3.49) 
P x 0.038 0.011 0.038 0.011 
Concentration of ceruloplasmin, mg/l 
 
497.9 
(462.9;509.5) 
389.4 
(331.2;414.3) 
443.6 
(328.3;529.6) 
357.0 
(314.1;456.1) 
347.4 
(291.8;400.5) 
P x 0.038 0.456 0.128 0.007 
Alanine aminotransferase activity in plasma, umol/(sec×l) 
 
1.32 
(1.27;1.64) 
1.23 
(1.17;1.29) 
1.10 
(0.85;1.25) 
1.11 
(0.96;1.22) 
1.11 
(0.87;1.18) 
P x 0.026 0.007 0.004 <0.001 
Activity of alkaline phosphatase in plasma, nmol/(sec×l) 
 
1193 
(1103;1722) 
1301 
(1179;1763) 
1301 
(1153;1532) 
1295 
(1216;1370) 
1310 
(1207;1383) 
P x 0.710 0.902 0.710 0.805 
Urea concentration in plasma, mmol/l 
 
1.84 
(1.74;1.91) 
1.77 
(1.76;1.86) 
1.73 
(1.71;1.97) 
1.66 
(1.65;1.71) 
1.72 
(1.63;2.30) 
P x 1.000 0.535 0.128 0.620 
Concentration of creatinine in plasma, umol/l 
 
54.8 
(44.2;54.8) 
50.6 
(42.1;58.0) 
50.6 
(40.1;54.8) 
46.3 
(42.1;57.0) 
48.3 
(42.9;51.8) 
P x 0.805 0.620 0.620 0.318 
 
The administration of ciprofloxacin, as 
well as its combination with antioxidants, does 
not lead to a decrease in the concentration of 
thiobarbiturate-reactive products and an 
increase in the content of reduced glutathione. 
The activity and glutathione peroxidase does 
not change. This indicates a persistent oxidative 
stress even against antibiotic chemotherapy. 
The only effect of ciprofloxacin (including in 
combination with ascorbic acid and 
methylethylpyridinol) is a decrease in catalase 
activity. Thus, despite a decrease in the plasma 
concentration of ceruloplasmin, ciprofloxacin 
does not cause a decrease in oxidative stress in 
animals with peritonitis caused by Klebsiella 
pneumoniae. Probably, this is due to its more 
severe course compared to infection caused by 
E. coli. Antioxidants also had a weak effect. 
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Hence it should be concluded that the 
effectiveness of the use of antioxidants in the 
complex therapy of bacterial infection depends 
not only on the mechanism of action of the 
antibacterial agent, but also on the specific 
pathogen. 
Just like ciprofloxacin, ceftazidime causes 
a decrease in oxydase activity of ceruloplasmin, 
but its combination with antioxidants affect this 
parameter ambiguously (Tables 7 and 8). 
In particular, the effect of the antibiotic is 
preserved in combination with ascorbic acid 
and methylethylpyridinol, but is lost in 
combination with N-acetylcysteine. In animals 
with an escherichiosis infection, on the 
contrary, the effect of ceftazidime is retained 
only in combination with N-acetylcysteine. 
 
Table 8 
Biochemical indices of rats with bacterial peritonitis caused by Klebsiella pneumoniae  
(with ceftazidimeadministration) 
 
P Group 1 Group 2 Group 3 Group 4 Group 5 
Erythrocyte catalase activity, %/mg Hb 
 
0.042 
(0.035;0.057) 
0.018 
(0.015;0.024) 
0.028 
(0.021;0.030) 
0.028 
(0.021;0.034) 
0.033 
(0.028;0.036) 
P x 0.002 0.004 0.011 0.073 
Concentration of reduced glutathione in erythrocytes, umol/g Hb 
 
0.51 
(0.45;0.60) 
0.68 
(0.60;0.74) 
0.56 
(0.53;0.67) 
0.60 
(0.53;0.74) 
0.60 
(0.50;0.66) 
P x 0.007 0.128 0.128 0.318 
Erythrocyte glutathione peroxidase activity, umol/(min× g Hb) 
 
18.52 
(17.44;19.98) 
20.95 
(19.07;22.38) 
20.19 
(18.37;21.36) 
20.98 
(19.12;21.57) 
19.02 
(18.20;19.42) 
P х 0.053 0.209 0.053 0.710 
Concentration of thiobarbiturate-reactive products, umol/l 
 
3.80 
(3.50;4.58) 
3.10 
(2.84;3.53) 
3.33 
(3.27;3.72) 
3.53 
(3.22;3.78) 
3.33 
(3.27;3.60) 
P x 0.017 0.097 0.165 0.073 
Concentration of ceruloplasmin, mg/l 
 
500.5 
(425.9;532.0) 
406.0 
(381.3;416.9) 
383.3 
(356.6;409.7) 
380.6 
(367.3;400.3) 
409.5 
(388.3;432.3) 
P x 0.026 0.011 0.011 0.073 
Alanine aminotransferase activity in plasma, umol/(sec×l) 
 
1.89 
(1.77;2.25) 
1.52 
(1.25;1.76) 
1.69 
(1.30;1.82) 
1.73 
(1.27;1.75) 
1.76 
(1.21;1.81) 
P x 0.026 0.073 0.053 0.038 
Activity of alkaline phosphatase in plasma, nmol/(sec×l) 
 
1557 
(1315;1748) 
1389 
(1187;1442) 
1404 
(1302;1493) 
1572 
(1306;1751) 
1464 
(1292;1628) 
P x 0.209 0.318 0.902 0.456 
Urea concentration in plasma, mmol/l 
 
1.81 
(1.60;2.33) 
2.04 
(1.96;2.12) 
2.27 
(1.93;2.54) 
2.17 
(1.91;2.36) 
2.14 
(2.08;2.39) 
P x 1.000 0.209 0.383 0.259 
Concentration of creatinine in plasma, umol/l 
 
45.3 
(43.7;47.9) 
44.81 
(44.2;46.0) 
47.6 
(46.6;49.9) 
47.8 
(46.4;51.1) 
51.3 
(48.6;52.7) 
P x 0.902 0.097 0.097 0.073 
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A characteristic effect that is caused by 
ceftazidime is a decrease in plasma activity of 
alanine aminotransferase, which indicates a 
decrease in liver damage in conditions of 
peritonitis, and is probably also a consequence 
of the antioxidant effect of the antibiotic. 
To confirm this, consider the peroxidation 
markers. In animals under the influence of 
ceftazidime, the concentration of 
thiobarbiturate-reactive products actually 
decreases. In this case, in combination with 
antioxidants, the effect does not increase in 
animals with escherichial peritonitis, and in 
animals with peritonitis caused by Klebsiella 
pneumoniae, on the contrary, it is lost. Similar 
changes are observed when considering the 
concentration of reduced glutathione. 
In animals with peritonitis caused by 
Klebsiella pneumoniae, antibiotic and its 
combination with antioxidants cause a decrease 
in the activity of erythrocyte catalase and an 
increase in the activity of glutathione 
peroxidase. With infection caused by Klebsiella 
pneumoniae, the activity of the latter does not 
change, and the combination with N-
acetylcysteine retains catalase activity at the 
control level. 
Thus, antioxidants in complex therapy of 
bacterial infection using ceftazidime have an 
ambiguous effect, which is due to the 
properties of the pathogen strain.If they did not 
affect the activity of the antibiotic in the 
therapy of escherichial peritonitis, then in the 
case of infection caused by Klebsiella 
pneumoniae, there is no definite regular 
influence. In addition, because of its instability, 
ceftazidime can have a very unstable 
pharmacokinetics. However, the decrease in 
antibiotic activity caused only N-acetylcysteine 
and only under conditions of infection caused 
by Klebsiella pneumoniae. This confirms the 
data obtained by us in vitro and demonstrates a 
decrease in the bactericidal effect of 
ceftazidime by N-acetylcysteine. 
Conclusion 
In vitro studies found that all antioxidants 
significantly reduce the activity of gentamicin. 
N-acetylcysteine also reduces the activity of 
ciprofloxacin and ceftazidime. 
Methylethylpyridinol increases the effect of 
ciprofloxacin, ceftazidime. Ascorbic acid 
enhances the action of ceftazidime. 
Ascorbic acid, methylethylpyridinol and 
N-acetylcysteine (80 mg/kg) reduce the 
antibacterial activity of gentamicin (30 mg/kg) 
and ciprofloxacin (50 mg/kg) and do not 
change the intensity of peroxidation processes 
when combined with these antibacterial agents 
under experimental infection conditions, caused 
by K. pneumoniae. These antioxidants reduce 
the pro-oxidant effect of ciprofloxacin (50 mg / 
kg) without affecting their antibacterial activity 
under experimental escherichiosis infection. 
Ascorbic acid, methylethylpyridinol and N-
acetylcysteine  
(80 mg/kg) do not reduce the nephrotoxic 
effect of gentamicin (30 mg/kg), but decrease 
its antibacterial efficacy. 
The use of substances that alter the activity 
of antibacterial agents has not only an obvious 
clinical, but also epidemiological significance. 
The use of any antibacterial agent leads to a 
gradual increase in the frequency of resistance 
of microorganisms. The time interval from the 
beginning of application of the drug to the 
moment of occurrence of 100% resistance is 
the time of effective use of the antibacterial 
agent. Inclusion in the chemotherapy of 
modulators-synergists, increasing the 
effectiveness of treatment, leads to an extension 
of this time. Modulators-antagonists, which 
reduce the activity of antibacterial agent, 
reduce the time of its effective use. 
The activity of each antioxidant essentially 
depends on the environment and the conditions 
of its functioning [21]. Another reason 
complicating the evaluation of antioxidant 
defense mechanisms is the interdependence of 
the content and activity of antioxidants 
combined into antioxidant systems. The effect 
of some antioxidants can be inverted when their 
content changes. In this regard, the effects 
exhibited by antioxidants are determined by the 
applied dose, by administration, 
biotransformation and elimination. 
The obtained data demonstrate that the 
existing traditional approach to determining the 
expediency of prescribing an antibacterial agent 
by microbiological evaluation of the 
susceptibility to the pathogen is insufficient in 
the context of complex pharmacotherapy. This 
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is due, above all, to the fact that other drugs can 
significantly change the sensitivity of bacteria 
to the chemotherapeutic agent until the 
development of resistance. Therefore, in order 
to increase the effectiveness of 
pharmacotherapy and reduce the occurrence of 
antibiotic resistant strains, it is necessary to 
conduct in vitro microbiological studies with 
all drugs planned for the treatment of the 
patient, as well as the causative agent that 
caused the disease, since the type of interaction 
of antibacterial agents and modulator 
substances is determined not only by 
mechanisms the effects of these drugs, but also 
the characteristics of a particular strain of the 
microorganism. 
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